Health
Antibodies deplete cancer cells in mice and human cell lines; reach previously inaccessible targets – EurekAlert
Three studies – one each in Science, Science Translational Medicine, and Science Immunology – reveal the promise of newly engineered bispecific antibodies, including…
Three studies – one each in Science, Science Translational Medicine, and Science Immunology – reveal the promise of newly engineered bispecific antibodies, including by demonstrating their power against previously inaccessible tumor cell targets for the first time, in two cases. These bispecific antibodies, which simultaneously bind to tumor antigens and T cells, cleared cancer cells without damaging healthy cells in mouse tumor models and/or cell culture experiments, across the three studies. The…
-
General24 hours agoDairy farmers devastated by floods across parts of New South Wales
-
Noosa News21 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
Noosa News24 hours agoMan dies in Gold Coast after rolling trailer pins him to lamp-post
-
General20 hours agoSussan Ley’s office says Bridget McKenzie made false claims about cabinet solidarity